Jonathan Rubin
Hoofd Techniek/Wetenschap/O&O bij SUPERNUS PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Jonathan Rubin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 | - |
Corporate Officer/Principal | 01-02-2020 | 01-01-2021 |
Loopbaan van Jonathan Rubin
Eerdere bekende functies van Jonathan Rubin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Atentiv LLC
Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Hoofd Techniek/Wetenschap/O&O | 01-05-2018 | 01-02-2020 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Hoofd Techniek/Wetenschap/O&O | 26-08-2013 | 01-09-2017 |
Shire Development LLC | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Jonathan Rubin
Yale University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
The University of Connecticut School of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Israël | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 3 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
Shire Development LLC | |
Atentiv LLC
Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Technology Services |
- Beurs
- Insiders
- Jonathan Rubin
- Ervaring